HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes

Background HbA1c variability has been linked to retinopathy, renal disease and autonomic neuropathy in patients with type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2D). Although the same relationship has been demonstrated for diabetic peripheral neuropathy (DPN) in patients with T2D, data for T1D are still lacking. Methods Patients older than 17 years of age with >= 10 years of T1D duration and follow-up were included. All patients underwent nerve conduction studies and neurological examination. Laboratorial data was retrospectively extracted from chart review. Mean HbA1c (mHbA1c) over 10 years was calculated, as well as HbA1c variability estimated by standard deviation (HbA1c-SD) and coefficient of variation (HbA1c-CV). Results Fifty patients with T1D were included (30 females and 21 non-caucasians), with mean age and T1D duration of 25.6 +/- 5.0 and 17.9 +/- 6.1 years, respectively. The frequency of DPN was 24%. Higher mHbA1c (10.4 +/- % vs 8.1 +/- %; p < 0.001), HbA1c-SD (1.8 +/- 0.8 vs 0.9 +/- 0.4; p < 0.001), and HbA1c-CV (1.7 +/- 0.8 vs 1.2 +/- 1.1; p = 0.006) were observed in patients with DPN compared to others. SD-HbA1c and HbA1c-CV were associated with DPN, diagnosed by either clinical or NCS criteria, independent of mHbA1c, age and gender. Conclusions Not only long-term glycemic control, but also its variability is associated with DPN in patients with T1D. Larger studies are required to confirm this finding.